Combination of micelles and liposomes as a promising drug delivery system: a review

被引:19
作者
Qian, Jiecheng [1 ]
Guo, Yankun [3 ,4 ]
Xu, Youfa [1 ,2 ]
Wang, Xinyu [1 ]
Chen, Jianming [1 ,2 ]
Wu, Xin [1 ,2 ,5 ]
机构
[1] Fujian Univ Tradit Chinese Med, Dept Pharm, Fuzhou, Peoples R China
[2] Shanghai Wei Er Lab, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Skin Dis Hosp, Dept Pharm, Sch Med, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Dept Pharm, Org Dept, Shanghai Gen Hosp,Sch Med, Shanghai, Peoples R China
[5] Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery MOE, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Micelle; Liposome; Drug delivery; Nanoformulation; Composite carrier; POLYMERIC MICELLES; RESPONSIVE LIPOSOMES; TARGETED DELIVERY; ULTRASOUND; NANOPARTICLES; STRATEGIES; CISPLATIN; TUMOR; GEMCITABINE; PACLITAXEL;
D O I
10.1007/s13346-023-01368-x
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
Among various nanocarriers, liposomes, and micelles are relatively mature drug delivery systems with the advantages of prolonging drug half-life, reducing toxicity, and improving efficacy. However, both have problems, such as poor stability and insufficient targeting. To further exploit the excellent properties of micelles and liposomes and avoid their shortcomings, researchers have developed new drug delivery systems by combining the two and making use of their respective advantages to achieve the goals of increasing the drug loading capacity, multiple targeting, and multiple drug delivery. The results have demonstrated that this new combination approach is a very promising delivery platform. In this paper, we review the combination strategies, preparation methods, and applications of micelles and liposomes to introduce the research progress, advantages, and challenges of composite carriers.
引用
收藏
页码:2767 / 2789
页数:23
相关论文
共 144 条
[1]   Approved and marketed nanoparticles for disease targeting and applications in COVID-19 [J].
Abdellatif, Ahmed A. H. ;
Alsowinea, Abdullah Fahad .
NANOTECHNOLOGY REVIEWS, 2021, 10 (01) :1941-1977
[2]   Micro and nanoscale technologies in oral drug delivery [J].
Ahadian, Samad ;
Finbloom, Joel A. ;
Mofidfar, Mohammad ;
Diltemiz, Sibel Emir ;
Nasrollahi, Fatemeh ;
Davoodi, Elham ;
Hosseini, Vahid ;
Mylonaki, Ioanna ;
Sangabathuni, Sivakoti ;
Montazerian, Hossein ;
Fetah, Kirsten ;
Nasiri, Rohollah ;
Dokmeci, Mehmet Remzi ;
Stevens, Molly M. ;
Desai, Tejal A. ;
Khademhosseini, Ali .
ADVANCED DRUG DELIVERY REVIEWS, 2020, 157 :37-62
[3]   Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[4]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[5]   Advances in Oral Drug Delivery [J].
Alqahtani, Mohammed S. ;
Kazi, Mohsin ;
Alsenaidy, Mohammad A. ;
Ahmad, Muhammad Z. .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[6]   A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents [J].
Andra, Veera Venkata Satya Naga Lakshmi ;
Bhatraju, Lakshmi Venkata Krishna Priya ;
Ruddaraju, Lakshmi Kalyani .
BIONANOSCIENCE, 2022, 12 (01) :274-291
[7]   Future Prospect of RNA Interference for Cancer Therapies [J].
Ashihara, Eishi ;
Kawata, Eri ;
Maekawa, Taira .
CURRENT DRUG TARGETS, 2010, 11 (03) :345-360
[8]   Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies [J].
Ballerini, Patrizia ;
Contursi, Annalisa ;
Bruno, Annalisa ;
Mucci, Matteo ;
Tacconelli, Stefania ;
Patrignani, Paola .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[9]   DIFFUSION OF UNIVALENT IONS ACROSS LAMELLAE OF SWOLLEN PHOSPHOLIPIDS [J].
BANGHAM, AD ;
STANDISH, MM ;
WATKINS, JC .
JOURNAL OF MOLECULAR BIOLOGY, 1965, 13 (01) :238-+
[10]  
Boulikas T, 2004, ONCOL REP, V12, P3